Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 4
2020 4
2021 7
2022 8
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Obermayer A, Tripolt NJ, Pferschy PN, Kojzar H, Aziz F, Müller A, Schauer M, Oulhaj A, Aberer F, Sourij C, Habisch H, Madl T, Pieber T, Obermayer-Pietsch B, Stadlbauer V, Sourij H. Obermayer A, et al. Among authors: sourij c. Diabetes Care. 2023 Feb 1;46(2):463-468. doi: 10.2337/dc22-1622. Diabetes Care. 2023. PMID: 36508320 Free PMC article. Clinical Trial.
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study).
Moser O, Müller A, Aberer F, Aziz F, Kojzar H, Sourij C, Obermayer A, Abbas F, Birnbaumer P, Lenz J, Mursic I, Sternad C, Hönger L, Ziko H, Pferschy PN, Tripolt N, Sourij H. Moser O, et al. Among authors: sourij c. Diabetes Technol Ther. 2023 Mar;25(3):161-168. doi: 10.1089/dia.2022.0422. Epub 2023 Jan 2. Diabetes Technol Ther. 2023. PMID: 36516429 Clinical Trial.
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination.
Paar M, Aziz F, Sourij C, Tripolt NJ, Kojzar H, Müller A, Pferschy P, Obermayer A, Banfic T, Di Geronimo Quintero B, Goswami N, Schlagenhauf A, Köstenberger M, Bärnthaler T, Wagner T, Hrzenjak A, Wonisch W, Reibnegger G, Raggam RB, Sourij H, Cvirn G. Paar M, et al. Among authors: sourij c. Viruses. 2022 Dec 20;15(1):10. doi: 10.3390/v15010010. Viruses. 2022. PMID: 36680051 Free PMC article.
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
Aberer F, Moser O, Aziz F, Sourij C, Ziko H, Lenz J, Abbas F, Obermayer AM, Kojzar H, Pferschy PN, Müller A, Unteregger C, Leitner M, Banfic T, Eckstein ML, Wachsmuth N, Kaser S, Mader JK, Tripolt NJ, Sourij H. Aberer F, et al. Among authors: sourij c. Diabetes Care. 2022 Feb 1;45(2):e24-e26. doi: 10.2337/dc21-1563. Diabetes Care. 2022. PMID: 34848490 No abstract available.
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.
Obermayer A, Tripolt NJ, Aziz F, Högenauer C, Aberer F, Schreiber F, Eherer A, Sourij C, Stadlbauer V, Svehlikova E, Brunner M, Goswami N, Kojzar H, Pferschy PN, Pieber TR, Sourij H. Obermayer A, et al. Among authors: sourij c. Biomolecules. 2021 Apr 14;11(4):574. doi: 10.3390/biom11040574. Biomolecules. 2021. PMID: 33919949 Free PMC article.
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Sourij C, Aziz F, Kojzar H, Obermayer AM, Sternad C, Müller A, Tripolt NJ, Pferschy PN, Aberer F, Schlenke P, Kleinhappl B, Stradner M, Sareban N, Moritz M, Dominguez-Villar M, Oliver N, Steinmetz I, Sourij H. Sourij C, et al. Diabetes Obes Metab. 2023 Jan;25(1):314-318. doi: 10.1111/dom.14855. Epub 2022 Sep 15. Diabetes Obes Metab. 2023. PMID: 36057945 Free PMC article. No abstract available.
Effects of 8 weeks of aerobic endurance training on functional capacity and metabolic variables in people with type 1 diabetes: A secondary outcome analysis of the ULTRAFLEXI-1 study.
Müller A, Moser O, Sternad C, Aziz F, Unteregger C, Kojzar H, Mursic I, Sourij C, Pferschy P, Tripolt N, Aberer F, Sourij H. Müller A, et al. Among authors: sourij c. Diabetes Obes Metab. 2023 Aug 14. doi: 10.1111/dom.15245. Online ahead of print. Diabetes Obes Metab. 2023. PMID: 37580976 No abstract available.
27 results